- Home
- AURA vs NPCE Comparison
AURA vs NPCE Comparison
Compare AURA & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AURA
- NPCE
- Stock Information
- Founded
- AURA 2007
- NPCE 1997
- Country
- AURA United States
- NPCE United States
- Employees
- AURA N/A
- NPCE N/A
- Industry
- AURA Biotechnology: Pharmaceutical Preparations
- NPCE Medical Specialities
- Sector
- AURA Health Care
- NPCE Health Care
- Exchange
- AURA Nasdaq
- NPCE Nasdaq
- Market Cap
- AURA 396.8M
- NPCE 363.2M
- IPO Year
- AURA 2021
- NPCE 2021
- Fundamental
- Price
- AURA $6.37
- NPCE $10.62
- Analyst Decision
- AURA Strong Buy
- NPCE Strong Buy
- Analyst Count
- AURA 5
- NPCE 6
- Target Price
- AURA $21.80
- NPCE $16.67
- AVG Volume (30 Days)
- AURA 294.2K
- NPCE 116.7K
- Earning Date
- AURA 11-13-2025
- NPCE 11-04-2025
- Dividend Yield
- AURA N/A
- NPCE N/A
- EPS Growth
- AURA N/A
- NPCE N/A
- EPS
- AURA N/A
- NPCE N/A
- Revenue
- AURA N/A
- NPCE $88,570,000.00
- Revenue This Year
- AURA N/A
- NPCE $22.13
- Revenue Next Year
- AURA N/A
- NPCE $6.07
- P/E Ratio
- AURA N/A
- NPCE N/A
- Revenue Growth
- AURA N/A
- NPCE 23.32
- 52 Week Low
- AURA $4.35
- NPCE $6.03
- 52 Week High
- AURA $11.33
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- AURA 55.74
- NPCE 53.23
- Support Level
- AURA $5.62
- NPCE $10.42
- Resistance Level
- AURA $6.16
- NPCE $11.14
- Average True Range (ATR)
- AURA 0.36
- NPCE 0.48
- MACD
- AURA 0.03
- NPCE -0.06
- Stochastic Oscillator
- AURA 76.46
- NPCE 42.97
About AURA Aura Biosciences Inc.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.